WELL Health Technologies Corp
TSX:WELL
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
3.67
7.26
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CAD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
WELL Health Technologies Corp
In the digital age of healthcare, WELL Health Technologies Corp. emerges as a quiet but formidable innovator, weaving technology and wellness into a comprehensive ecosystem. Founded in 2010, the company has grown from its Canadian roots to become a major player in the health-tech landscape, driven by a mission to modernize and improve healthcare access. WELL Health operates primarily within the electronic medical records (EMR) sector, offering physicians and clinics a seamless transition from traditional paper-based systems to robust digital platforms. With a series of strategic acquisitions, WELL has expanded its portfolio to include telehealth services, medical services, and digital health applications, effectively building an integrated network that caters to both healthcare providers and patients. This blend of services positions WELL Health as a pioneer in overhauling how healthcare systems interact with technology, thereby laying the groundwork for a more efficient, patient-centric approach.
WELL Health Technologies generates revenue through a multifaceted business model that hinges on its diverse array of service lines. The company earns by licensing its EMR software to clinics and practitioners, ensuring a steady stream of recurring revenue. Additionally, its telehealth services, which provide virtual healthcare consultations, have gained traction, especially amid the increased demand for remote healthcare solutions. The acquisition strategy further enriches WELL’s revenue sources, allowing it to tap into various niche markets such as cybersecurity for healthcare data and provider billing services. These services not only diversify WELL Health’s income streams but also enhance the value proposition to its users by offering a one-stop shop for healthcare solutions. Through a carefully orchestrated expansion, WELL Health Technologies continues to redefine the synergy between health and technology, anchoring itself firmly as a vital conduit in the ever-evolving healthcare domain.
In the digital age of healthcare, WELL Health Technologies Corp. emerges as a quiet but formidable innovator, weaving technology and wellness into a comprehensive ecosystem. Founded in 2010, the company has grown from its Canadian roots to become a major player in the health-tech landscape, driven by a mission to modernize and improve healthcare access. WELL Health operates primarily within the electronic medical records (EMR) sector, offering physicians and clinics a seamless transition from traditional paper-based systems to robust digital platforms. With a series of strategic acquisitions, WELL has expanded its portfolio to include telehealth services, medical services, and digital health applications, effectively building an integrated network that caters to both healthcare providers and patients. This blend of services positions WELL Health as a pioneer in overhauling how healthcare systems interact with technology, thereby laying the groundwork for a more efficient, patient-centric approach.
WELL Health Technologies generates revenue through a multifaceted business model that hinges on its diverse array of service lines. The company earns by licensing its EMR software to clinics and practitioners, ensuring a steady stream of recurring revenue. Additionally, its telehealth services, which provide virtual healthcare consultations, have gained traction, especially amid the increased demand for remote healthcare solutions. The acquisition strategy further enriches WELL’s revenue sources, allowing it to tap into various niche markets such as cybersecurity for healthcare data and provider billing services. These services not only diversify WELL Health’s income streams but also enhance the value proposition to its users by offering a one-stop shop for healthcare solutions. Through a carefully orchestrated expansion, WELL Health Technologies continues to redefine the synergy between health and technology, anchoring itself firmly as a vital conduit in the ever-evolving healthcare domain.
Record Revenue: WELL Health reported Q3 2025 revenue of $364.6 million, up 56% year-over-year, with record results across multiple operating segments.
Profitability Surge: Adjusted EBITDA jumped 296% to $59.9 million, driven partly by deferred revenue from Circle Medical and strong operational performance.
Margin Improvement: Gross margin improved by 510 basis points to 45.5%, and adjusted EBITDA margin rose by 990 basis points year-over-year.
Guidance Reaffirmed: Management reaffirmed 2025 revenue guidance of $1.4–$1.45 billion and expects annual adjusted EBITDA to hit the upper half of $190–$210 million.
M&A Pipeline: The company has a robust M&A pipeline, with $235 million in Canadian clinics under LOI and over $350 million in targeted annual revenue pipeline.
US Divestitures: Strategic review of US assets (WISP, Circle Medical, CRH) is ongoing, with at least one sale targeted by year-end.
WELLSTAR Spin-Out: WELLSTAR secured $62 million in equity financing at a premium valuation, with an IPO targeted for early 2026.
Operational Expansion: Canadian clinics visit volume and provider count continue to rise, with strong organic growth and efficiency gains.
